Shapiro, A. D., Angchaisuksiri, P., Astermark, J., Benson, G., Castaman, G., Eichler, H., . . . Chowdary, P. (2022). Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.
Citación estilo ChicagoShapiro, Amy D., et al. Long-term Efficacy and Safety of Subcutaneous Concizumab Prophylaxis in Hemophilia A and Hemophilia A/B With Inhibitors. 2022.
Cita MLAShapiro, Amy D., et al. Long-term Efficacy and Safety of Subcutaneous Concizumab Prophylaxis in Hemophilia A and Hemophilia A/B With Inhibitors. 2022.
Precaución: Estas citas no son 100% exactas.